COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:

Carisoprodol (78-44-4)


Study Results


Genetic Toxicology

An overview of Genetic Toxicology Micronucleus Mice study conclusions related to Carisoprodol (78-44-4).
Micronucleus - Mice
View
  • Male: Negative
    Female: Negative
An overview of Genetic Toxicology Mammalian Cell Mutagenicity study conclusions related to Carisoprodol (78-44-4).
Mammalian Cell Mutagenicity
View
  • Positive
An overview of Genetic Toxicology Mammalian Cell Cytogenetics study conclusions related to Carisoprodol (78-44-4).
Mammalian Cell Cytogenetics
CA SCE
An overview of Genetic Toxicology Bacterial Mutagenicity study conclusions related to Carisoprodol (78-44-4).
Bacterial Mutagenicity
View
  • Negative

Citation Information


NTP. Carisoprodol (78-44-4). Chemical Effects in Biological Systems (CEBS). Research Triangle Park, NC (USA): National Toxicology Program (NTP).

Publications


TOX-56 Toxicity Studies of Carisoprodol (CASRN 78-44-4) Administered by Gavage to F344/N Rats and B6C3F1 Mice
Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K, Speck W. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ Mutagen. 1987;9 Suppl 9:1-109.
Witt, K.L., Knapton, A., Wehr, C.M., Hook, G.J., Mirsalis, J., Shelby, M.D., and MacGregor, J.T. Micronucleated Erythrocyte Frequency in Peripheral Blood of B6C3F1 Mice from Short-Term, Prechronic, and Chronic Studies of the NTP Carcinogenesis Bioassay Program. Environ. Molec. Mutagen. Vol. 36 (2000) 163-194

Study Data


Toxicity and Carcinogenicity Studies


3-Month Evaluation of the Toxicity (C56235A) of Carisoprodol (78-44-4) in F344 Rats Exposed via Gavage. NTP Special Study
3-Month Evaluation of the Toxicity (C56235A) of Carisoprodol (78-44-4) in B6C3F1 Mice Exposed via Gavage. NTP Special Study
3-Month Evaluation of the Toxicity (C56235B) of Carisoprodol (78-44-4) in F344/N Rats Exposed via Gavage
3-Month Evaluation of the Toxicity (C56235C) of Carisoprodol (78-44-4) in F344/N Rats Exposed via Gavage
3-Month Evaluation of the Toxicity (C56235B) of Carisoprodol (78-44-4) in B6C3F1 Mice Exposed via Gavage
3-Month Evaluation of the Toxicity (C56235C) of Carisoprodol (78-44-4) in B6C3F1 Mice Exposed via Gavage

Genetic Toxicology Studies


Genetic Toxicity Evaluation of Carisoprodol (78-44-4) in Micronucleus Study A09820 in B6C3F1 Mice
Genetic Toxicity Evaluation of Carisoprodol in Salmonella/E.coli Mutagenicity Test or Ames Test. Study 238333
Summary Data